Financial News
UNM Q3 2026 deep dive: disability claim surge drives earnings shortfall despite solid sales

Employee benefits provider Unum Group (NYSE: UNM) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 4.6% year on year to $3.40 billion. Its non-GAAP profit of $2.20 per share was 1.6% above analysts’ consensus estimates.
Is now the time to buy UNM? Find out in our full research report (it’s free for active Edge members).
Unum Group (UNM) Q3 2026 highlights:
- Revenue $3.40 billion vs S&P analysts’ estimates of $3.06 billion (4.6% year-on-year growth, 11% beat)
- Adjusted EPS $2.20 vs S&P analysts’ estimates of $2.17 (1.6% beat)
- Market capitalization $14.41 billion
StockStory’s take
Unum Group’s third quarter was marked by a significant rise in disability claim submissions in both the U.S. and U.K., which management identified as the central factor behind the company’s earnings shortfall. CEO Rick McKenney described the quarter as “challenging,” noting that while core operations premium growth and customer retention remained healthy, the spike in long-term disability claims—particularly behavioral health cases—was unexpected. The company’s other segments, including Colonial Life and supplemental lines, continued to perform within expectations, but these results could not offset the pressures from elevated disability claims. Management emphasized that these claim dynamics were not linked to competitive changes or internal adjudication shifts, but rather a broader increase in people submitting claims.
Looking ahead, Unum Group’s guidance will be heavily influenced by ongoing trends in disability claims and the effectiveness of repricing actions across its group insurance portfolio. Management is implementing double-digit rate increases, especially in paid family and medical leave products, and expects these adjustments to work through the business over the renewal cycle. CFO Steve Zabel acknowledged continued uncertainty regarding the duration and magnitude of the claims surge, stating, “We remain cautious about the increase in submissions… and are prepared to take further corrective action if these trends persist.” The company believes it can return to its long-term target benefit ratios over time, but cautioned that the timing will depend on how claim patterns develop in the coming quarters.
Key insights from management’s remarks
Management attributed the quarter’s underperformance primarily to a sudden increase in disability claim submissions, particularly behavioral health-related, while highlighting steady premium growth and ongoing capital return initiatives.
-
Disability claim surge: Management reported a sharp increase in long-term disability (LTD) claim submissions in the U.S., with a 10% rise above expected levels, primarily driven by behavioral health cases. These claims tend to be more volatile and are influenced by external labor market uncertainties.
-
Repricing actions underway: To address elevated claims, Unum is actively repricing affected group insurance products, especially paid family and medical leave (PFML), where double-digit rate hikes are being applied at renewal. Management explained that PFML’s lack of multi-year rate guarantees enables quicker pricing response, while LTD repricing will phase in as new experience data is incorporated.
-
International pressures persist: The U.K. group income protection business also faced higher than expected claim submissions, particularly behavioral health cases, prompting earlier and ongoing pricing and underwriting adjustments. Management stated that while these measures will take time to impact profitability, they are necessary to restore margins.
-
Diverse segment performance: While group disability experienced headwinds, Colonial Life and U.S. supplemental and voluntary lines posted strong results, driven by lower cancer claims and steady premium growth. This diversification helped balance overall earnings but was insufficient to counteract the disability pressures.
-
Progress on LTC risk reduction: The company completed a second reinsurance transaction to offload long-term care (LTC) exposure, reducing LTC statutory reserves by approximately 40%. Management views this as an important milestone in de-risking the closed block and improving overall capital flexibility.
Drivers of future performance
Management’s outlook centers on the pace of disability claim normalization, the impact of repricing initiatives, and ongoing capital deployment.
-
Claims trend uncertainty: The company’s future earnings will depend on whether the current surge in disability claim submissions is temporary or signals a longer-lasting shift in incidence, particularly for behavioral health claims. Management emphasized that adjudication outcomes and claim approvals may lag submissions, adding unpredictability to near-term results.
-
Repricing and margin recovery: Ongoing repricing—especially for PFML and group disability—should begin restoring margins as renewed contracts reflect higher rates. Management highlighted that most group business is renewable annually, allowing for relatively rapid pricing adjustments, though the full effect may not be seen until later renewal cycles.
-
Capital strength and deployment: Unum expects to maintain strong capital and liquidity positions, supporting continued shareholder returns through dividends and buybacks. However, the trajectory of future capital deployment will be reassessed in light of disability claim trends and underlying business performance.
Catalysts in upcoming quarters
Looking forward, our analysts will closely monitor (1) the progression of disability claim submissions and any signs of normalization in behavioral health cases, (2) the effectiveness and pace of repricing actions across group insurance lines, particularly in PFML and LTD, and (3) continued progress on de-risking the long-term care closed block. We will also track capital return execution and the company’s ability to maintain strong persistency and premium growth in core segments.
Unum Group currently trades at $73.19, down from $91.03 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).
Now could be the perfect time to invest in these stocks
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View MoreRecent Quotes
View MoreQuotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
